Collaborative Care for Substance Use and Mental Health Disorders
Trial Summary
What is the purpose of this trial?
This is a research study to assess the effectiveness of a peer-led collaborative care model for integrating treatment for substance use and or mental health disorders into HIV care settings. Depending on whether or not participants enroll in this study, participants will be assigned randomly (by chance, like drawing a number from a hat) to one of two groups. In group 1, participants would receive usual clinical care. In group 2, participants would work with a peer-case manager who would help support participants to engage in substance use or mental health disorder care. Regardless of the group participants are in, participants will fill out a survey when first enrolled in the study, and then again 12 months later.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but it requires that participants are not currently receiving treatment for mental health or substance use disorders.
What data supports the effectiveness of the treatment Peer Supported Collaborative Care for Substance Use and Mental Health Disorders?
Research shows that collaborative care models, which involve team-based approaches to integrate mental health and medical care, are effective in improving outcomes for mental health conditions in primary care settings. Additionally, peer support, which involves individuals with lived experience providing support to others, has been shown to improve health outcomes and lower system costs when integrated into clinical settings.12345
Is Collaborative Care for Substance Use and Mental Health Disorders safe for humans?
Collaborative Care models, including those with peer support, have been implemented in various healthcare settings and are generally considered safe. They focus on improving mental health care through teamwork and support, and while challenges exist in integration, no specific safety concerns have been highlighted in the research.23678
How is the Peer Supported Collaborative Care treatment different from other treatments for substance use and mental health disorders?
Research Team
Oluwaseun Falade-Nwulia, MD
Principal Investigator
Johns Hopkins School of Medicine
Eligibility Criteria
This trial is for adults aged 18-99 receiving HIV care who aren't currently treated for mental health or substance use disorders. They must speak English and have screened positive for these disorders at the Bartlett HIV clinic.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are assigned to either usual care or a peer-supported collaborative care model for mental health and substance use disorder treatment integrated into HIV care settings
Follow-up
Participants are monitored for changes in mental health and substance use disorder outcomes and HIV virologic suppression
Treatment Details
Interventions
- Peer Supported Collaborative Care
Peer Supported Collaborative Care is already approved in United States for the following indications:
- Substance Use Disorders
- Mental Health Disorders
- HIV Care
Find a Clinic Near You
Who Is Running the Clinical Trial?
Johns Hopkins University
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Collaborator